Literature DB >> 26410257

Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile.

Amar Mandalia1, Angela Ward2, William Tauxe1, Colleen S Kraft3, Tanvi Dhere4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26410257      PMCID： PMC4808452          DOI： 10.1007/s00384-015-2396-2

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  10 in total

Review 1.  The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.

Authors:  Taha Qazi; Thelina Amaratunga; Edward L Barnes; Monika Fischer; Zain Kassam; Jessica R Allegretti
Journal:  Gut Microbes       Date:  2017-09-12

2.  Analysis of risk factors for early clinical recurrence of inflammatory bowel disease after fecal microbiota transplantation.

Authors:  Di Zhao; Chen Ye; Shaoyi Zhang; Xiaoqiong Lv; Bo Yang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

3.  Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders.

Authors:  Hani Sbahi; Jack A Di Palma
Journal:  BMJ Open Gastroenterol       Date:  2016-05-09

Review 4.  Fecal microbiota transplantation in metabolic syndrome: History, present and future.

Authors:  P F de Groot; M N Frissen; N C de Clercq; M Nieuwdorp
Journal:  Gut Microbes       Date:  2017-02-27

5.  Fecal microbiota transplantation in recurrent Clostridium difficile infection: A retrospective single-center chart review.

Authors:  Pamela Kim; Akash Gadani; Heitham Abdul-Baki; Ricardo Mitre; Marcia Mitre
Journal:  JGH Open       Date:  2018-10-15

6.  Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.

Authors:  Fengqin Su; Yi Luo; Jian Yu; Jimin Shi; Yanmin Zhao; Mengni Yan; He Huang; Yamin Tan
Journal:  Eur J Med Res       Date:  2021-04-28       Impact factor: 2.175

7.  Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies.

Authors:  Lamprinos Michailidis; Alden C Currier; Michelle Le; Deborah R Flomenhoft
Journal:  Ann Gastroenterol       Date:  2021-07-02

8.  Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis.

Authors:  Gianluca Ianiro; Marcello Maida; Johan Burisch; Claudia Simonelli; Georgina Hold; Marco Ventimiglia; Antonio Gasbarrini; Giovanni Cammarota
Journal:  United European Gastroenterol J       Date:  2018-06-03       Impact factor: 4.623

9.  Fecal transplantation for treatment of inflammatory bowel disease.

Authors:  Aamer Imdad; Maribeth R Nicholson; Emily E Tanner-Smith; Joseph P Zackular; Oscar G Gomez-Duarte; Dawn B Beaulieu; Sari Acra
Journal:  Cochrane Database Syst Rev       Date:  2018-11-13

10.  A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients.

Authors:  Oluwaseun Shogbesan; Dilli Ram Poudel; Samjeris Victor; Asad Jehangir; Opeyemi Fadahunsi; Gbenga Shogbesan; Anthony Donato
Journal:  Can J Gastroenterol Hepatol       Date:  2018-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.